After Hemophilia Deal, UniQure Sees Zolgensma As Model For Huntington’s Gene Therapy

Focused On Long-Term Gene Therapy Leadership

 
• By Andrew McConaghie
  
uniQure
uniQure had been tipped as a top M&A target for 2020
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip